Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for PBH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2004. Start Trial.
Date Value
June 30, 2026 0.00
March 31, 2026 0.312M
December 31, 2025 45.82M
September 30, 2025 74.25M
June 30, 2025 31.62M
March 31, 2025 8.851M
December 31, 2024 -6.346M
September 30, 2024 10.20M
June 30, 2024 24.00M
March 31, 2024 -7.271M
December 31, 2023 -1.635M
September 30, 2023 -2.155M
June 30, 2023 17.97M
March 31, 2023 -0.199M
December 31, 2022 -5.684M
September 30, 2022 12.27M
June 30, 2022 36.24M
March 31, 2022 -1.322M
December 31, 2021 -3.011M
September 30, 2021 -0.503M
June 30, 2021 -2.204M
March 31, 2021 0.466M
December 31, 2020 8.838M
September 30, 2020 0.928M
June 30, 2020 -1.216M
Date Value
March 31, 2020 6.428M
December 31, 2019 -0.463M
September 30, 2019 20.94M
June 30, 2019 28.49M
March 31, 2019 0.00
December 31, 2018 -1.903M
September 30, 2018 -0.148M
June 30, 2018 49.10M
March 31, 2018 -0.154M
December 31, 2017 0.00
September 30, 2017 -1.033M
June 30, 2017 -0.433M
March 31, 2017 -0.584M
December 31, 2016 -0.021M
September 30, 2016 -0.018M
June 30, 2016 -3.405M
March 31, 2016 -0.089M
December 31, 2015 -0.202M
September 30, 2015 -0.07M
June 30, 2015 -6.872M
March 31, 2015 -0.30M
December 31, 2014 -0.897M
September 30, 2014 -1.463M
June 30, 2014 -1.351M
March 31, 2014 -0.169M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Indivior Pharmaceuticals, Inc. 175.35M
ANI Pharmaceuticals, Inc. 0.505M
Corcept Therapeutics, Inc. -9.42M
Veru, Inc. -0.001M
Johnson & Johnson -138.00M